Something old, Something New: Radiation and Immunotherapy in Soft Tissue Sarcoma

Abstract

for soft tissue sarcoma [18], despite promising phase II data [19]. Although the result was negative, it is worth noting that the trial was successful in enrolling 509 patients and reporting conclusive results within 5 years of opening. Radiation for soft tissue sarcomaThe variation in a slurry of heat killed bacteria and difficulty in gaining approvals after the advent of the FDA caused Coley's